BioArctic AB Forecast, price target & analysts
BioArctic AB Target price 2025 - Analyst rating & recommendation
BioArctic AB Classifications & Recommendation:
BioArctic AB Price Target
| Target Price | kr318.75 |
| Price | kr294.80 |
| Potential |
8.12%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target BioArctic AB 2026 .
The average BioArctic AB target price is kr318.75.
This is
8.12%
register free of charge
kr372.75
26.44%
register free of charge
kr222.20
24.63%
register free of charge
|
|
| A rating was issued by 10 analysts: 8 Analysts recommend BioArctic AB to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BioArctic AB stock has an average upside potential 2026 of
8.12%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion kr | 0.26 | 2.06 |
| 58.22% | 699.30% | |
| EBITDA Margin | -82.15% | 58.97% |
| 278.81% | 171.78% | |
| Net Margin | -68.81% | 51.28% |
| 284.89% | 174.53% |
7 Analysts have issued a sales forecast BioArctic AB 2025 . The average BioArctic AB sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an BioArctic AB EBITDA forecast 2025. The average BioArctic AB EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 BioArctic AB Analysts have issued a net profit forecast 2025. The average BioArctic AB net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share kr | -2.00 | 11.92 |
| 177.22% | 696.00% | |
| P/E | 24.74 | |
| EV/Sales | 11.53 |
6 Analysts have issued a BioArctic AB forecast for earnings per share. The average BioArctic AB EPS is
This results in the following potential growth metrics and future valuations:
Current BioArctic AB Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RX SECURITIES |
Locked
➜
Locked
|
Locked | Sep 01 2025 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | May 21 2025 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | May 20 2025 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Feb 16 2025 |
| DNB MARKETS |
Locked
➜
Locked
|
Locked | Feb 16 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Sep 01 2025 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
May 21 2025 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
May 20 2025 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Mar 24 2025 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Feb 16 2025 |
|
Locked
DNB MARKETS:
Locked
➜
Locked
|
Feb 16 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
